Found: 7
Select item for more details and to access through your institution.
Editorial: Genetic basis of tolerance induction defects underlying the development of autoimmune pathologies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1069232
- By:
- Publication type:
- Article
Mixed Chimerism and Growth Factors Augment β Cell Regeneration and Reverse Late-Stage Type 1 Diabetes.
- Published in:
- Science Translational Medicine, 2012, v. 4, n. 133, p. 1, doi. 10.1126/scitranslmed.3003835
- By:
- Publication type:
- Article
Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Interferon-γ Limits Diabetogenic CD8<sup>+</sup> T-Cell Effector Responses in Type 1 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Induction of Mixed Chimerism Depletes Pre-existing and De Novo-Developed Autoreactive B Cells in Autoimmune NOD Mice.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Induction of Mixed Chimerism Depletes Pre-existing and De Novo–Developed Autoreactive B Cells in Autoimmune NOD Mice.
- Published in:
- Diabetes, 2014, v. 63, n. 6, p. 2051, doi. 10.2337/db13-1532
- By:
- Publication type:
- Article
Induction of Chimerism Permits Low-Dose Islet Grafts in the Liver or Pancreas to Reverse Refractory Autoimmune Diabetes.
- Published in:
- Diabetes, 2010, v. 59, n. 9, p. 2228, doi. 10.2337/db10-0450
- By:
- Publication type:
- Article